The revised outlook, filed via an 8-K report, placed revenue guidance at $2.4 billion, falling roughly $560 million short of Wall Street’s $2.96 billion consensus. Fluence management cited persistent U.S. supply-chain constraints and significant delays at its Houston contract-manufacturing facility as primary drivers for the shortfall. Despite reporting a record $6.4 billion backlog and $1.44 billion in quarterly orders, the company admitted an inability to convert these commitments into cash and revenue on schedule.
Financial institutions reacted swiftly to the news. Baird slashed its price target by 70%, while BMO lowered its target from $14 to $7. Goldman Sachs shifted its rating to Neutral, and Zacks downgraded the stock to Strong Sell. Law firm Levi & Korsinsky is now reviewing whether the company provided materially misleading statements regarding its fiscal outlook and its operational capacity to process its backlog, inviting investors who suffered losses to have their claims evaluated.

Comments (0)
No comments yet. Be the first!